Measuring in vivo tumor pHe with CEST-FISP MRI.
Measuring in vivo tumor pHe with CEST-FISP MRI.
复制标题
DOI:
10.1002/mrm.23038
复制
发表时间:
2012-03
影响因子:
3.3
通讯作者:
Pagel, Mark D.
中科院分区:
文献类型:
--
作者:
Sheth, Vipul R.;Li, Yuguo;Chen, Liu Qi;Howison, Christine M.;Flask, Chris A.;Pagel, Mark D.
PARACEST MRI contrast agents have been developed that can measure pH in solution studies, but these agents have not previously been detected in vivo. In order to use the PARACEST agent Yb-DO3A-oAA to measure the extracellular pH (pHe) in tumor tissue, a CEST-FISP MRI protocol was developed, the saturation period was optimized for sensitive CEST detection, and median filtering was used to remove artifacts in CEST spectra. These improvements were used to correlate pH with a ratio of two CEST effects of Yb-DO3A-oAA at a 7T magnetic field strength (R2 = 0.99, standard deviation of precision = 0.011 pH units). The PARACEST agent could not be detected in tumor tissue following i.v. injection due to the low sensitivity of in vivo CEST MRI. Yb-DO3A-oAA was detected in tumor tissue and leg muscle after directly injecting the PARACEST agent into these tissues. The measured CEST effects were used to measure a tumor pH of 6.82 ± 0.21 and a leg muscle pH of 7.26 ± 0.14, and parametric pH maps were also generated from these tissue regions. These results demonstrated that tumor pHe can be measured with a PARACEST agent and a rapid CEST-MRI protocol.
登录
查看更多内容
影响因子:
3.3
作者:
Shah, T.;Lu, L.;Dell, K. M.;Pagel, M. D.;Griswold, M. A.;Flask, C. A.
通讯作者:
Flask, C. A.
影响因子:
3.3
作者:
Liu, Guanshu;Li, Yuguo;Pagel, Mark D.
通讯作者:
Pagel, Mark D.
影响因子:
10.6
作者:
Chan, RH;Ho, CW;Nikolova, M
通讯作者:
Nikolova, M
影响因子:
6.7
作者:
Parmelee, DJ;Walovitch, RC;Lauffer, RB
通讯作者:
Lauffer, RB
影响因子:
3.3
作者:
Kim M;Gillen J;Landman BA;Zhou J;van Zijl PC
通讯作者:
van Zijl PC